000 01324 a2200397 4500
005 20250513234715.0
264 0 _c20010621
008 200106s 0 0 eng d
022 _a0378-5173
024 7 _a10.1016/s0378-5173(01)00593-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, K E
245 0 0 _aPharmacokinetics of a new antitumor 3-arylisoquinoline derivative, CWJ-a-5.
_h[electronic resource]
260 _bInternational journal of pharmaceutics
_cApr 2001
300 _a101-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xblood
650 0 4 _aArea Under Curve
650 0 4 _aBile
_xmetabolism
650 0 4 _aBiological Availability
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aIsoquinolines
_xpharmacokinetics
650 0 4 _aMale
650 0 4 _aProtein Binding
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSolubility
700 1 _aCho, W J
700 1 _aChang, S J
700 1 _aYong, C S
700 1 _aLee, C H
700 1 _aKim, D D
773 0 _tInternational journal of pharmaceutics
_gvol. 217
_gno. 1-2
_gp. 101-10
856 4 0 _uhttps://doi.org/10.1016/s0378-5173(01)00593-2
_zAvailable from publisher's website
999 _c11227742
_d11227742